Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$37.95 - $58.98 $3.45 Million - $5.36 Million
90,888 New
90,888 $3.74 Million
Q4 2022

Feb 09, 2023

SELL
$42.17 - $58.6 $1.4 Million - $1.95 Million
-33,300 Reduced 12.99%
223,000 $12.5 Million
Q3 2022

Nov 10, 2022

BUY
$42.28 - $57.17 $10.8 Million - $14.7 Million
256,300 New
256,300 $10.9 Million
Q2 2022

Aug 05, 2022

SELL
$53.86 - $66.52 $2.02 Million - $2.5 Million
-37,567 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$62.86 - $69.24 $188,580 - $207,719
-3,000 Reduced 7.4%
37,567 $2.41 Million
Q4 2021

Feb 11, 2022

SELL
$62.47 - $73.25 $5.18 Million - $6.07 Million
-82,901 Reduced 67.14%
40,567 $2.72 Million
Q3 2021

Nov 12, 2021

BUY
$64.97 - $76.19 $2.35 Million - $2.76 Million
36,239 Added 41.54%
123,468 $8.46 Million
Q2 2021

Aug 12, 2021

BUY
$66.79 - $76.63 $5.83 Million - $6.68 Million
87,229 New
87,229 $5.95 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.91B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.